MRS was used to examine the aging effects of glutamate in participants with schizophrenia versus healthy controls. The parietal lobe and hippocampus, regions associated with general aging and the pathophysiology of schizophrenia, were assessed. Results revealed that hippocampal glutamate was lower in older adults with schizophrenia versus older controls. In contrast, parietal glutamate was lower in schizophrenia versus controls, irrespective of age group. These results suggest that the hippocampus may be particularly vulnerable to aging in schizophrenia. Interventions that halt hippocampal glutamate decline may be beneficial for patients with schizophrenia.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords